top of page
Image by National Cancer Institute

Companion Diagnostics Development

Facilitating personalised treatment

Companion Diagnostics Innovation

Leveraging our diagnostic development expertise and clinical experience to create companion diagnostics that are critical for identifying the right patients for the right treatments, enabling a more precise, targeted approach to treatment, improving patient outcomes, and advancing the field of medicine, from clinical trials through to commercialisation.

Development & Optimisation

Creating assays that can detect biomarkers with high sensitivity and specificity involve leveraging our expertise in NGS to develop reliable, reproducible diagnostic solutions.

Biomarker Discovery & Validation

Identifying and validating biomarkers that predict the efficacy and safety of pharmaceuticals, ensuring that treatments can be personalised to individual genetic profiles.

Regulatory Excellence

Navigating the complex regulatory landscape of companion diagnostics, which involves close coordination with drug development timelines and regulatory submissions. Our team is driven to ensure that our solutions meet all relevant regulatory requirements.

Image by Muhammad Syafi Al - adam


Working collaboratively with our customers, our genomic experts customise NGS panels, laboratory workflows and analysis pipelines to meet individual demand and needs.


Get in touch with us for an initial consultation to discuss your project and what we can offer.

bottom of page